Search results
PROMOTED
Author(s):
Rafal Dworakowski, Khung Keong Yeo, Andrew Cook ,et al
Start date:
Mar 18, 2026
Join leading international experts for an in-depth, case-based masterclass focused on transcatheter edge-to-edge repair (TEER) in secondary mitral regurgitation (MR). This webinar will explore how anatomical variations influence procedural planning, leaflet grasping strategies, and execution techniques, delivering practical insights you can apply directly to clinical practice.Chaired by Prof…
View more
Author(s):
S. Chris Malaisrie
Added:
10 months ago
CRT 25 - Dr S. Chris Malaisrie (Northwestern University, Evanston, US) joins us to discuss the five-year outcomes from the PARTNER 3 aortic valve-in-valve registry (NCT02675114). The prospective, randomized, multi-center study aimed to assess TAVR with the Edwards SAPIEN 3 transcatheter heart valve (Edwards Lifesciences) compared to aortic valve replacement with a commercially available surgical…
View more
Author(s):
Jonathan Curio
,
Henning Guthoff
,
Stephan Nienaber
,
et al
Added:
8 months ago
Choice of Transcatheter Aortic Valve Prosthesis
Author(s):
Arif A Khokhar
,
Jonathan Curio
,
Matthew Hammond-Haley
,
et al
Added:
2 months ago
Review Article
Author(s):
Carla Agiatiello
Added:
1 month ago
Navigate real-world tricuspid valve intervention challenges with Dr Carla AgatielloThis presentation, part of Women As One's CLIMB® 2025 Skills Training Program on Structural Interventions, brings practical insights from the evolving landscape of tricuspid procedures in Latin America, where these innovative interventions represent the cutting edge of structural heart disease management.Dr…
View more
Author(s):
Santiago Garcia
Added:
7 months ago
New York Valves 2025 -Dr Santiago Garcia (The Christ Hospital, Cincinnati, OH, US) joins us to discuss outcomes from an observational study investigating early outcomes of the Navitor self-expandable transcatheter valve with intra-annular leaflet position. Approximately 3,000 patients with severe, symptomatic aortic stenosis, high surgical risk and tricuspid anatomy were enrolled in the study and…
View more
Author(s):
Vlasis Ninios
Added:
2 months ago
PCR London Valves 2025 - Dr Vlasis Ninios (Interbalkan European Medical Center, GR) discusses one-year outcomes from the AltaValve Early Feasibility Study, evaluating a novel atrial fixation system for transcatheter mitral valve replacement in patients with severe mitral regurgitation.This prospective, single-arm, multicenter study enrolled high surgical risk patients with moderate to severe or…
View more
Author(s):
Jonathan Schwartz
Added:
2 months ago
PCR London Valves 2025 - In this interview, Dr Jonathan Schwartz, leading structural interventional cardiologist at the Sanger Heart and Vascular Institute, Lake Forest University (Charlotte, NC, US) shares his insights into the evolving landscape of transcatheter tricuspid valve therapies.Dr Schwartz examines the latest real-world and clinical trial evidence for the EVOQUE and TriClip systems,…
View more
Author(s):
Added:
7 months ago
New York Valves 25 - Quantitative findings from Tri-QOL showed a strong correlation between tricuspid regurgitation (TR) reduction and KCCQ improvement after transcatheter tricuspid valve intervention (TTVI).Dr Suzanne Arnold (Saint Luke's Mid America Heart Institute, Kansas City, US) discusses findings from a quantitative analysis from the Tri-QOL study which aimed to assess the optimal result…
View more
Aortic Valve Calcium, Aortic Stenosis and TAVI
Author(s):
James Krzowski
,
Jonathan Weir-McCall
,
Luigia D’Errico
,
et al
Added:
9 months ago
Review Article